Dr. Raajit Chanana 
Senior Consultant
14 Years of ExperienceMedical Oncologist
MBBS, MD, DM, Fellowship
Reg. No.:DMC/R/6939
Dharamshila Narayana Superspeciality Hospital, New Delhi
English, Hindi
Consultation Fee ₹ 1000
Book an AppointmentAbout Dr. Raajit Chanana
- Dr. Raajit Chanana is a well-known and expert medical oncologist. He comes with about 14 years of experience to offer precision-based cancer treatment.
- He is skilled in offering treatment services for different types of cancers, such as gastrointestinal, genitourinary, lung, and breast cancer.
- He specializes in offering cancer treatment to his patients with
- Chemotherapy
- Immunotherapy
- Targeted therapy
- Precision medicine
- Dr. Raaji Chanana pursued an MBBS from Maulana Azad Medical College in 2010. He then specialized in Internal Medicine by pursuing an MD from Lady Hardinge Medical College in 2014.
- He also completed a DM in Medical Oncology at Tata Memorial Hospital in 2017.
- He is an active leader and participant in clinical trials, hence offering novel and advanced methods of treatment for his patients.
- Further, his constant attendance at international conferences keeps him up-to-date in practicing novel and innovative techniques and learning new skills.
- Dr. Raajit Chanana is also focused on cancer awareness and imparting necessary education regarding its prevention and awareness.
Book Your Appointment With Dr. Raajit Chanana
Get a Treatment Plan Within 1 Hour
Education
- MBBS - Maulana Azad Medical College, 2010
- MD - Internal Medicine - Lady Hardinge Medical College, 2014
- DM - Medical Oncology - Tata Memorial Hospital, 2017
- Fellow in Paediatric Cardiac Surgery at Mater Medical School, University of Queensland, Brisbane
Training & Certificates
- European Certified Medical Oncologist
Past Experience
- Specialist Registrar in Department of Medical Oncology at Tata Memorial Hospital, 2018
- Clinical Associate in Paediatric Cardiac Surgery at Sevenhills Hospital Marol-Maroshi, Mumbai
- Lecturer in School of Medicine, Mater Medical School under the University of Queensland, Brisbane
Associations/Membership
- Medical Council of India
- Delhi Medical Council
- Indian Society of Medical and Pediatric Oncology
- American Society of Clinical Oncology
- European Society of Medical Oncology
Paper Published
He has multiple publications to his credit. A few among them are:
- Thorat, J., Sengar, M., Chanana, R., Kapoor, A., Singh, A., Bonda, A., ... & Jain, H. (2024). A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted EPOCH (+/? R) Regimen. Indian Journal of Hematology and Blood Transfusion, 40(1), 36–42.
- Chandrakanth, M. V., Agarwala, V., Mondal, P., Chanana, R., Parthasarathy, K. M., Dutta, S., ... & Kumar, S. (2023). Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and metastatic squamous cell carcinoma of head and neck: a retrospective analysis from two institutions in India. F1000Research, 12, 802.
- Jain, H., Kapoor, A., Sengar, M., Chanana, R., Menon, H., Sridhar, E., ... & Gujral, S. (2021). Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience. Indian Journal of Hematology and Blood Transfusion, 37, 379-385.
- Jain, H., Rengaraj, K., Sharma, V., Bonda, A., Chanana, R., Thorat, J., ... & Sengar, M. (2020). Infection prevalence in adolescents and adults with acute myeloid leukemia treated in an Indian tertiary care center. JCO Global Oncology, 6, 1684-1695.
- Agarwala, V., Chandrakanth, M. V., Mondal, P. K., & Chanana, R. (2020). 275P Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and metastatic squamous cell carcinoma of head and neck: A double institution retrospective analysis from India. Journal of Oncology, p. 31, S1350.
- Sengar, M., Carr, R., Jain, H., Chanana, R., Rangarajan, V., Sridhar, E., ... & Laskar, S. (2020). Outcomes of T-lymphoblastic lymphoma treated with pediatric ALL-like protocol. Indian Journal of Cancer, 57(3), 262-266.
- Chanana, R., Prabhash, K., Noroha, V., Joshi, A., Patil, V., & Nakti, D. (2018). A retrospective study was conducted to evaluate treatment outcomes of Pleural Mesothelioma treated in a tertiary care center in India. Annals of Oncology, 29, vii75-vii76.
- Chanana, R., Noronha, V., Joshi, A., Patil, V., & Prabhash, K. (2018). The evolving role of immunotherapy in head-and-neck cancers: a systematic review. Journal of Head & Neck Physicians and Surgeons, 6(1), 2–11.
Field of Expertise
- Adrenal Cancer Treatment
- Bacillus Calmette Guerin (BCG) Therapy
- Benign and Cancerous Tumor Excision
- Bile Duct Cancer Treatment
- Bone Marrow Transplant
- Brain Tumor Surgery
Best Oncology Doctors in India
Dr. Ashok Kumar Vaid
Chairman
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Book an Appointment Talk To Expert
Dr. Satya Pal Kataria
Vice Chairman
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Book an Appointment Talk To Expert
Dr. Chandragouda Dodagoudar
Director
Medical Oncologist
BLK-Max Super Speciality Hospital, New Delhi
Book an Appointment Talk To Expert
Dr. Kunjahari Medhi
Senior Director
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Book an Appointment Talk To Expert